EGFR-mutation testing, treatment patterns and clinical outcomes in patients with stage IB–IIIA non-small cell lung cancer in Norway–a nationwide cohort study

EGFR-mutation testing, treatment patterns and clinical outcomes in patients with stage IB–IIIA non-small cell lung cancer in Norway–a nationwide cohort study

Introduction: Testing for mutations of epidermal growth factor receptor (EGFR) is crucial to identify non-small cell lung cancer (NSCLC) patients eligible for treatment with EGFR tyrosine kinase inhibitors (EGFR-TKIs); This study aims to describe EGFR-mutation testing, treatment patterns, and overal...

Full description

Bibliographic Details
Main Authors: Åslaug Helland, Tor Åge Myklebust, Simona Conte, Line Elmerdahl Frederiksen, Jørgen Aarøe, Espen Enerly
Format: Article
Language:English
Published: Elsevier 2024-01-01
Series:Cancer Treatment and Research Communications
Subjects:
Non-small cell lung cancer
Epidermal growth factor receptor
Tyrosine kinase inhibitors
Real-world evidence
Overall survival
Online Access:http://www.sciencedirect.com/science/article/pii/S2468294223001077

Internet

http://www.sciencedirect.com/science/article/pii/S2468294223001077

Similar Items